(Q42876512)

9 November 2017

Gastric Cancer Working Group report (English)

1 reference

9 November 2017

2

Manami Inoue

1 reference

9 November 2017

6

Atsushi Ohtsu

1 reference

9 November 2017

Mitsuru Sasako

1

1 reference

9 November 2017

Jaw-Town Lin

series ordinal

3

1 reference

9 November 2017

Christopher Khor

series ordinal

4

1 reference

9 November 2017

Han-Kwang Yang

series ordinal

5

1 reference

9 November 2017

1 September 2010

1 reference

Japanese Journal of Clinical Oncology

9 November 2017

1 reference

9 November 2017

40 Suppl 1

1 reference

9 November 2017

i28-37

1 reference

Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer.

9 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Asia-Pacific consensus guidelines on gastric cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Detection of early gastric cancer: misunderstanding the role of mass screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Endoscopic resection of early gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Longterm outcomes after endoscopic mucosal resection for early gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Surgical treatment of advanced gastric cancer: Japanese perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Chemotherapy for metastatic gastric cancer: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

Lymphadenectomy for gastric adenocarcinoma: should west meet east?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ124

21 January 2018

Identifiers

DOI

10.1093/JJCO/HYQ124

1 reference

9 November 2017

1 reference